or Try an Advanced Search...

    Respiratory Diseases Stocks List

    Symbol Grade Name % Change
    WINT F Windtree Therapeutics, Inc. -5.53
    REVB F Revelation Biosciences, Inc. -6.36
    GILD F Gilead Sciences, Inc. 2.14
    SMLR F Semler Scientific, Inc. -0.17
    EHAB F Enhabit, Inc. 0.60
    VRNA F Verona Pharma plc 0.68
    VMD F Viemed Healthcare, Inc. 0.21
    SVRA D Savara, Inc. -8.19
    ALVO C Alvotech -1.69
    SPRY C ARS Pharmaceuticals, Inc. -0.68
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Care Facilities Medical Devices
    Related Stock Lists: Medicine Disease Cystic Fibrosis Respiratory Therapy Allergology Cardiovascular Disease Chronic Disease Diabetes Heart Disease Hypertension Infection Nasal Administration Osteoporosis Pharmaceutical Therapy Services Vascular Disease Allergy Alzheimer's Disease Anaphylaxis Angina

    Related ETFs - A few ETFs which own one or more of the above listed Respiratory Diseases stocks.

    Symbol Grade Name Weight
    PPH B Market Vectors Pharmaceutical ETF 12.22
    MEDX D Horizon Kinetics Medical ETF 10.95
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 7.55
    XLV C SPDR Select Sector Fund - Health Care 6.17
    IYH C iShares U.S. Healthcare ETF 6.03
    View all Respiratory Diseases ETFs...
    Compare ETFs
    Compare FTXH to XLV Compare MEDX to FTXH Compare PPH to FTXH

        Respiratory Diseases Stocks Recent News

        Date Stock Title
        Feb 7 VMD (Exclusive) Stocks To Watch, PRO+ Edition
        May 10 REVB Revelation Biosciences GAAP EPS of -$2.46
        May 10 REVB Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
        May 10 EHAB Enhabit Inc (EHAB) Reports Mixed Q1 2024 Results: Challenges and Strategic Adjustments Highlighted
        May 10 VRNA Verona Pharma PLC Reports Q1 2024 Earnings: A Detailed Financial and Strategic Overview
        May 10 VRNA Verona Pharma plc (NASDAQ:VRNA) Q1 2024 Earnings Call Transcript
        May 9 SPRY ARS Pharmaceuticals GAAP EPS of -$0.11
        May 9 SVRA Savara GAAP EPS of -$0.11 misses by $0.01
        May 9 GILD Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
        May 9 GILD Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 SVRA Savara Reports First Quarter 2024 Financial Results and Provides Business Update
        May 9 SPRY ARS Pharmaceuticals Highlights neffy Regulatory Progress and Reports First Quarter 2024 Financial Results
        May 9 VRNA Verona Pharma gets $650M in financing ahead of June FDA decision on COPD asset
        May 9 VRNA Verona Pharma plc (VRNA) Q1 2024 Earnings Call Transcript
        May 9 GILD Gilead's FOCUS Program Helps Zero In on Early HIV Detection
        May 9 EHAB AREX Capital Expresses Disappointment in Enhabit’s Strategic Review Conclusion
        May 9 EHAB Enhabit challenged by hedge fund AREX Capital seeking seven board seats - report
        May 9 VRNA Verona Pharma GAAP EPS of -$0.04 beats by $0.09
        May 9 VRNA Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 9 VRNA Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
        Related Industries: Biotechnology Drug Manufacturers - Major Drug Manufacturers - Specialty & Generic Medical Appliances & Equipment Medical Care Facilities Medical Devices
        Related Stock Lists: Medicine Diabetes Respiratory Therapy Asthma Cancer Chronic Condition Chronic Disease Chronic Obstructive Pulmonary Disease Cystic Fibrosis Disease Heart Disease Heart Failure Hypertension Life Sciences Medication Osteoporosis Pain Pharmaceutical Therapy Services Acid
        Respiratory Diseases

        Respiratory diseases are a group of conditions that affect the lungs and airways. These diseases can range from mild to severe and can include asthma, COPD, pneumonia, and lung cancer. Symptoms of respiratory diseases can include difficulty breathing, coughing, wheezing, and chest pain. Treatment for respiratory diseases can include medications, lifestyle changes, and surgery.

        Browse All Tags